My watch list
my.bionity.com  
Login  

Neurotune

News Neurotune

  • Neurotune Strengthens Management

    Neurotune AG announced personnel changes in its board of directors as well as management. Dr. Raimund Eckel will form the Board of Directors together Mr. Gerhard Musshafen and Dr. Bruno Oesch (Chairman). Furthermore, Dr. Armin W. Mäder, former CFO of Neurotune assumes the CEO position of Neurotune f more

  • New members for Neurotune's Board of Directors

    The shareholders of Neurotune AG have elected Dr. Anders Härfstrand and Heinrich Rotach as new members of the board of directors at their annual general assembly on April 21, 2010. Anders Härfstrand is a medical doctor with extensive experience in neuropharmacology and an excellent track record as e more

  • Neurotune announces regulatory approval for Phase II Clinical Trial to treat neuropathic pain in HIV patients

    Neurotune AG has received MCC ’s (the South African National Regulatory Agency) approval for a Phase II clinical study of neurotune’s lead compound NT-11624 for neuropathic pain caused by treatment with anti-retroviral medication. Neurotune’s Phase II trial (8-week, randomized, double-blind, placeb more

All news on neurotune

Market studies Neurotune

Websites Neurotune

NiKem Research: Complete Drug Discovery Services

FAQs Brochure Home Latest News! NiKem Research Receives Authorization for Rodent Toxicology Studies (May 3rd, 2010) NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chr more

About us - Neurotune - Drugs for muscles and brains

About us Navigation überspringen Home About us Management Board of Directors Scientific Advisory Team Therapeutic Areas Pipeline Investors Careers News Events Contact   Neurotune develops medications to treat disorders of the human nervous system and is developing treatments, which modulate (tune) t more

Neurotune - Drugs for muscles and brains

    Home About us Therapeutic Areas Pipeline Investors Careers News Contact     Neurotune, based in Schlieren (Zurich), Switzerland, was incorporated in January 2005 as a spin-off from Prionics AG. Neurotune develops small-molecules into potential drugs to treat Neurological Disorders including musc more

All websites on neurotune

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE